Evaluation of Impacts of Access to Credit and Loan Size for Microcredit Clients in South Africa

NCT00700349 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3000

Last updated 2008-06-18

No results posted yet for this study

Summary

This study involves randomization of individuals who were initially rejected from a micro-lending organization in South Africa. Subjects were placed into two arms: (1) not receiving a loan; (2) being reconsidered for a "second look." Of those in the second arm, 53% were then selected by the organization's loan officers to receive a standard loan for first-time borrowers. Mental health and financial data were collected at one timepoint: approximately 6-12 months after the subjects first applied for the loan.

Conditions

Interventions

OTHER

Small loan

Applicants in the treatment group were offered an interest rate, loan size, and maturity per the lender's standard underwriting criteria, involving a 4-month maturity at 11.75% per month, charged on the original balance (200% annual percentage rate).

Sponsors & Collaborators

  • Broadening Access and Strengthening Input Market Systems/USAID

    collaborator UNKNOWN
  • U.S. National Science Foundation

    collaborator FED
  • Bill and Melinda Gates Foundation

    collaborator OTHER
  • Princeton University

    collaborator OTHER
  • Social Science Research Council Program in Applied Economics

    collaborator UNKNOWN
  • Federal Reserve Bank of New York

    collaborator UNKNOWN
  • Innovations for Poverty Action

    lead OTHER

Principal Investigators

  • Dean Karlan, PhD · Innovations for Poverty Action

  • Jonathan Zinman, PhD · Dartmouth University

  • Lia Fernald, PhD · University of California, Berkeley

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-09-30
Primary Completion
2005-11-30
Completion
2005-11-30

Countries

  • South Africa

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00700349 on ClinicalTrials.gov